← Back to Search

Behavioral Intervention

Text Message Education for Heart Disease in HIV/AIDS

N/A
Recruiting
Led By Megan McLaughlin, MD, MPH
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least 40 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial will explore if text messages can reduce heart disease risk in people living with HIV.

Who is the study for?
This trial is for English-speaking adults over 40 years old who are living with HIV but do not have existing cardiovascular disease. Participants must own a smartphone and be willing to provide informed consent. Pregnant individuals cannot participate.Check my eligibility
What is being tested?
The TEACH-HIV trial is testing whether educational text messages can help reduce the risk of heart disease in people with HIV. The effectiveness of these digital messages will be evaluated over time.See study design
What are the potential side effects?
Since this intervention involves receiving educational text messages, there are no direct medical side effects associated with it.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 40 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of participants with controlled blood pressure
Secondary outcome measures
Blood sugar control
Body mass index
Cholesterol
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
The intervention arm will receive education about HIV and heart disease risk via mobile phone text messages for up to 6 months. They will receive the text messages 3-5 times per week. The messages will include information about HIV and risk of heart disease and information about how to reduce heart disease risk. The intervention arm will also receive brief monthly surveys via a digital research platform.
Group II: Control ArmActive Control1 Intervention
The control arm will not receive the educational text messages. They will receive brief monthly surveys via a digital research platform.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,295 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,836 Previous Clinical Trials
47,850,597 Total Patients Enrolled
Megan McLaughlin, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco

Media Library

Digital Educational Messaging (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05642858 — N/A
HIV/AIDS Research Study Groups: Intervention Arm, Control Arm
HIV/AIDS Clinical Trial 2023: Digital Educational Messaging Highlights & Side Effects. Trial Name: NCT05642858 — N/A
Digital Educational Messaging (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05642858 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open for the trial at this time?

"Unfortunately, based on the information available at clinicaltrials.gov, this trial is not currently seeking participants; however, it was posted on January 1st 2023 and last updated November 29th 2022. Fortunately for those in search of a medical study to join, there are 1139 other trials recruiting patients presently."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Zuckerberg San Francisco General Hospital
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
2
Recent research and studies
clinicaltrials.govStudy
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
2023. "Text Education About Cardiovascular Health and HIV (TEACH-HIV)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05642858.
All > Atherosclerosis
~35 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top